Crysvita

Crysvita - Psychology, Special Needs, Health - Posted: 17th Apr, 2018 - 11:54pm

Text RPG Play Text RPG ?
 

Posts: 1 - Views: 126
Drug for x-linked hypophosphatemia (XLH)
Post Date: 17th Apr, 2018 - 11:54pm / Post ID: #

NOTE: News [?]

Crysvita

The U.S. Food and Drug Administration today approved Crysvita (Burosumab), the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH), a rare, inherited form of rickets. XLH causes low levels of phosphorus in the blood. It leads to impaired bone growth and development in children and adolescents and problems with bone mineralization throughout a patient’s life. Source 3n.

Sponsored Links:

 
> TOPIC: Crysvita
 

▲ TOP


International Discussions Coded by: BGID®
ALL RIGHTS RESERVED Copyright © 1999-2024
Disclaimer Privacy Report Errors Credits
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in our Cookies used here: Privacy / Disclaimer,